January 2013

Volume 21 Issue 1

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com
All three categories of PE patients should not be treated the same. It is evident we should be treating these patients differently and we should be more aggressive with the massive and submassive patients.
At 12 months, the LifeStent was far superior to balloon angioplasty with regard to target lesion revascularization and had better patency by duplex ultrasound.
Once the cells are placed into a leg that has low oxygen because of poor blood flow, the cells change themselves or they behave differently, growing new small blood vessels and releasing various cytokines that can affect healing.
DEFINITIVE AR seeks to prove that there is an additional benefit to performing atherectomy prior to the use of a drug-eluting balloon.
DEBATE BTK looked at patients with diabetes and critical limb ischemia undergoing revascularization with either the Medtronic Invatec In.Pact Amphirion DEB or an uncoated balloon, in occluded or stenotic tibial vessels with lesions of at least 40 mm.
In most cases, through retrograde recanalization, it is possible to recanalize the tibial vessel.
While most patients are asymptomatic from subclavian stenosis, some patients present with symptoms of upper extremity ischemia, including arm or hand claudication with or without neurologic symptoms or symptoms of subclavian steal syndrome.
After acquiring three other accreditations (Stroke Certification, Heart Failure Certification, and Chest Pain Center Certification), the cath lab at Forbes Regional Hospital decided to obtain ACE accreditation in April 2012.
Our case report is a first of its kind where the right subclavian artery was involved in a steal phenomenon from the left internal mammary artery graft.